Hercules Capital Appoints Two Senior Investment Professionals in New Leadership Roles
07 May 2019 - 8:00PM
Business Wire
R. Bryan Jadot to Lead Life Sciences Venture
Lending and Steve Kuo to Head Technology Venture Lending
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the
“Company”), the largest specialty financing provider to innovative
venture growth stage companies backed by leading venture capital
and private equity firms, today announced the promotions of R.
Bryan Jadot to Head of Life Sciences Venture Lending and Steve Kuo
to Head of Technology Venture Lending. Jadot and Kuo each served
long-term tenures of more than 13 years at Hercules, respectively,
and have made significant contributions to the growth of the
Company’s debt and equity investment portfolio which stands at more
than $2.1 billion today. Both will continue to report to Scott
Bluestein, interim chief executive officer and chief investment
officer of Hercules.
“Both Bryan and Steve have made significant contributions to the
firm, each demonstrating their industry insights and value to the
expansion and success of our industry-leading venture lending
platform,” stated Scott Bluestein. “Based on their proven track
record and experience growing our two largest investment groups, we
are proud to recognize them for their accomplishments and we look
forward to their continued leadership of our venture life sciences
and venture technology groups. I have worked closely with Bryan and
Steve since 2010 and I am confident that these promotions will
position us best for continued success and platform expansion.
Moving forward, we will continue to opportunistically and
strategically make investments in our organization that helps
achieve our growth objectives for the year and supports our vision
of becoming a broader provider of specialty debt financing
solutions.”
R. Bryan Jadot is the Head of Venture Lending for the
Life Sciences Group and brings nearly 20 years of financial and
credit structuring experience to Hercules. Prior to joining
Hercules in 2005, Mr. Jadot served as vice president of the Life
Sciences Group at Silicon Valley Bank in Newton, MA where he
co-managed a banking group dedicated to New England-based life
science clients including biotechnology, medical device, and
healthcare IT clients. He also worked as the vice president of the
Software Group at Silicon Valley Bank in Palo Alto, CA. Prior to
Silicon Valley Bank, Mr. Jadot worked with the Corporate Banking
arm of the Banque Nationale de Paris in San Francisco, CA and was
an assistant economist with the Department of Treasury’s Office of
Eastern Europe and former Soviet Union in Washington DC.
Steve Kuo is the Head of Venture Lending for the
Technology Group at Hercules and brings more than 16 years of
operational and structured finance experience. Since joining
Hercules in 2006, he has led over $1.2 billion in capital
investments. Mr. Kuo was appointed a co-head of Hercules Capital
SaaS Finance division in 2018 and has been involved with early
stage startups with passionate founders and great concepts as well
as billion-dollar revenue businesses looking to finance their next
big market. Prior to Hercules, he was a strategic member of
Lightcross, a silicon photonics startup, where he led the product
management team. Before joining Lightcross, he was a principal at
Comdisco Ventures.
About Hercules Capital, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) is the leading
and largest specialty finance company focused on providing senior
secured venture growth loans to high-growth, innovative venture
capital-backed companies in a broad variety of technology, life
sciences and sustainable and renewable technology industries. Since
inception (December 2003), Hercules has committed more than $8.9
billion to over 460 companies and is the lender of choice for
entrepreneurs and venture capital firms seeking growth capital
financing. Companies interested in learning more about financing
opportunities should contact info@htgc.com, or call
650.289.3060.
Hercules’ common stock trades on the New York Stock Exchange
(NYSE) under the ticker symbol “HTGC.” In addition, Hercules has
six outstanding bond issuances of:
Institutional Notes PAR $1000.00
Retail Notes (“Baby Bonds”) PAR $25.00
- 5.25% Notes due 2025 (NYSE: HCXZ)
- 6.25% Notes due 2033 (NYSE: HCXY)
Convertible Notes
- 4.375% Convertible Notes due 2022
Securitization Notes
- 4.605% Asset-backed Notes due 2027
- 4.703% Asset-backed Notes due 2028
Forward-Looking Statements
This press release may contain “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act
of 1995. You should understand that under Section 27A(b)(2)(B) of
the Securities Act of 1933, as amended, and Section 21E(b)(2)(B) of
the Securities Exchange Act of 1934, as amended, or the Exchange
Act, the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995 do not apply to forward-looking
statements made in periodic reports we file under the Exchange
Act.
The information disclosed in this press release is made as of
the date hereof and reflects Hercules’ most current assessment of
its historical financial performance. Actual financial results
filed with the SEC may differ from those contained herein due to
timing delays between the date of this release and confirmation of
final audit results. These forward-looking statements are not
guarantees of future performance and are subject to uncertainties
and other factors that could cause actual results to differ
materially from those expressed in the forward-looking statements
including, without limitation, the risks, uncertainties, including
the uncertainties surrounding the current market volatility, and
other factors the Company identifies from time to time in its
filings with the SEC. Although Hercules believes that the
assumptions on which these forward-looking statements are based are
reasonable, any of those assumptions could prove to be inaccurate
and, as a result, the forward-looking statements based on those
assumptions also could be incorrect. You should not place undue
reliance on these forward-looking statements. The forward-looking
statements contained in this release are made as of the date
hereof, and Hercules assumes no obligation to update the
forward-looking statements for subsequent events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190507005165/en/
Michael HaraInvestor Relations and Corporate
CommunicationsHercules Capital, Inc.(650)
433-5578mhara@htgc.com
Hercules Capital (NYSE:HTGC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hercules Capital (NYSE:HTGC)
Historical Stock Chart
From Jul 2023 to Jul 2024